This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (44) Citing Articles via Google Scholar Google Scholar Articles by Burnett, R. C. Articles by Avery, A. C. Search for Related Content PubMed PubMed Citation Articles by Burnett, R. C. Articles by Avery, A. C.

Diagnosis of Canine Lymphoid Neoplasia Using Clonal Rearrangements of Antigen Receptor Genes

Department of Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO (RCB, CSO, ACA); Department of Pathology, Microbiology, and Immunology, University of California, Davis, CA (WV, PFM); Department of Pathobiology, Texas A&M University, College Station, TX (JFM¹)

Although the diagnosis of canine leukemia and lymphoma in advanced stages is usually uncomplicated, some presentations of the disease can be a diagnostic challenge. In certain situations, lymphoma and leukemia can be difficult to distinguish from a benign reactive proliferation of lymphocytes. Because clonality is the hallmark of malignancy, we have developed an assay that uses the polymerase chain reaction to amplify the variable regions of immunoglobulin genes and T-cell receptor genes to detect the presence of a clonal lymphocyte population. The assay detected clonally rearranged antigen receptor genes in 91% of the 77 dogs with lymphoid malignancy. Of the 24 dogs tested, that were either healthy or had clearly defined conditions not related to lymphoid malignancy, a clonally rearranged antigen receptor gene was found in one (a dog with Ehrlichia canis infection). Gene rearrangement was appropriate for the immunophenotype (immunoglobulin gene rearrangement in B-cell leukemias and T-cell receptor gene rearrangement in T-cell leukemias). Dilution analysis showed that the clonal rearrangement could be detected when 0.1–10% of the DNA was derived from neoplastic cells, depending on the source tissue. Potential applications of this assay include the diagnosis of lymphoma or leukemia in biopsy samples, cavity fluids, fine needle aspirates, bone marrow and peripheral blood; the determination of lineage (B or T cell); staging of lymphoma; and detection of residual disease after chemotherapy.

Key words: Dogs; gene rearrangement; genes–immunoglobulin; leukemia; lymphoma; myeloma; receptors–antigen–T-cell.

Request reprints from Dr. A. C. Avery, Department of Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523 (USA). E-mail: anne.avery{at}colostate.edu.

This article has been cited by other articles:

				V. E. Valli, W. Vernau, L.-P de Lorimier, P. S. Graham, and P. F. Moore Canine Indolent Nodular Lymphoma Vet. Pathol., May 1, 2006; 43(3): 241 - 256. [Abstract] [Full Text] [PDF]

				J. A. Werner, J. C. Woo, W. Vernau, P. S. Graham, R. A. Grahn, L. A. Lyons, and P. F. Moore Characterization of Feline Immunoglobulin Heavy Chain Variable Region Genes for the Molecular Diagnosis of B-cell Neoplasia Vet. Pathol., September 1, 2005; 42(5): 596 - 607. [Abstract] [Full Text] [PDF]

				C. M. Jubala, J. W. Wojcieszyn, V. E. O. Valli, D. M. Getzy, S. P. Fosmire, D. Coffey, D. Bellgrau, and J. F. Modiano CD20 Expression in Normal Canine B Cells and in Canine non-Hodgkin Lymphoma Vet. Pathol., July 1, 2005; 42(4): 468 - 476. [Abstract] [Full Text] [PDF]

				J. F. Modiano, M. Breen, R. C. Burnett, H. G. Parker, S. Inusah, R. Thomas, P. R. Avery, K. Lindblad-Toh, E. A. Ostrander, G. C. Cutter, et al. Distinct B-Cell and T-Cell Lymphoproliferative Disease Prevalence among Dog Breeds Indicates Heritable Risk Cancer Res., July 1, 2005; 65(13): 5654 - 5661. [Abstract] [Full Text] [PDF]